STATE STREET CORP - PHATHOM PHARMACEUTICALS INC ownership

PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 104 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.4%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of PHATHOM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,922,971
-8.8%
667,596
+26.0%
0.00%
Q2 2023$7,587,352
+129.1%
529,843
+14.3%
0.00%
Q1 2023$3,311,125
-67.3%
463,743
-48.6%
0.00%
Q4 2022$10,128,272
+105.2%
902,698
+102.6%
0.00%
Q3 2022$4,936,000
+43.0%
445,495
+9.0%
0.00%
Q2 2022$3,451,000
-30.5%
408,882
+12.0%
0.00%
Q1 2022$4,968,000
-26.1%
365,044
+6.8%
0.00%
Q4 2021$6,726,000
-40.9%
341,940
-3.6%
0.00%
-100.0%
Q3 2021$11,388,000
-1.1%
354,764
+4.2%
0.00%0.0%
Q2 2021$11,519,000
+41.2%
340,303
+56.7%
0.00%
Q1 2021$8,158,000
+17.5%
217,198
+3.9%
0.00%
Q4 2020$6,945,000
-11.6%
209,050
-2.5%
0.00%
-100.0%
Q3 2020$7,859,000
+12.2%
214,307
+0.7%
0.00%0.0%
Q2 2020$7,003,000
+44.8%
212,807
+13.6%
0.00%
Q1 2020$4,836,000
+24.0%
187,308
+49.6%
0.00%
Q4 2019$3,900,000125,2430.00%
Other shareholders
PHATHOM PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Medicxi Ventures Management (Jersey) Ltd 2,067,861$40,675,00010.18%
FRAZIER MANAGEMENT LLC 5,827,415$114,625,0008.82%
Abingworth LLP 1,203,135$23,606,0005.72%
RA Capital Management 3,115,008$61,272,0001.08%
Avidity Partners Management LP 1,896,000$37,294,0000.79%
StepStone Group LP 422,085$8,302,0000.47%
Summit Rock Advisors, LP 34,100$671,0000.40%
Parkman Healthcare Partners LLC 77,481$1,524,0000.34%
Rhenman & Partners Asset Management AB 186,210$3,624,0000.24%
Ikarian Capital, LLC 74,560$1,467,0000.22%
View complete list of PHATHOM PHARMACEUTICALS INC shareholders